These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25651705)

  • 1. Serum ischemia-modified albumin and malondialdehyde levels and superoxide dismutase activity in patients with fibromyalgia.
    Toker A; Kucuksen S; Kucuk A; Cicekler H
    Clin Lab; 2014; 60(10):1609-15. PubMed ID: 25651705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of audiological complaints in patients with fibromyalgia syndrome and its relationship with oxidative stress.
    Koca TT; Seyithanoglu M; Sagiroglu S; Berk E; Dagli H
    Niger J Clin Pract; 2018 Oct; 21(10):1271-1277. PubMed ID: 30297558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?
    Bagis S; Tamer L; Sahin G; Bilgin R; Guler H; Ercan B; Erdogan C
    Rheumatol Int; 2005 Apr; 25(3):188-90. PubMed ID: 14689230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cataract progression and ischemia-modified albumin in relation to oxidant-antioxidant profiles in the serum, aqueous humor, and lens.
    Elmazar HM; Elmadbouh I; Mandour SS; Al Ariny GM; Ibrahim AM
    J Cataract Refract Surg; 2018 Feb; 44(2):134-139. PubMed ID: 29587970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Levels of Serum Ischemia Modified Albumin in Patients with Ankylosing Spondylitis.
    Türkön H; Gökmen F; Çakir DÜ; Sehitoğlu MH; Reşorlu H; Döner D; Eşsizoğlu E; Akbal A; Kizilkaya B; Uysal S
    Clin Lab; 2016; 62(4):645-9. PubMed ID: 27215084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.
    Keshavarzi F; Rastegar M; Vessal M; Rafiei Dehbidi G; Khorsand M; Ganjkarimi AH; Takhshid MA
    Metab Brain Dis; 2018 Jun; 33(3):675-680. PubMed ID: 29270710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oxidative stress in the relation between fibromyalgia and obstructive sleep apnea syndrome.
    Yildirim T; Alp R
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):20-29. PubMed ID: 28121361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism.
    Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Coskun H; Deger O
    Endocr Res; 2016 Nov; 41(4):350-360. PubMed ID: 27111422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidative stress in melasma: a prospective study on serum and blood markers of oxidative stress in melasma patients.
    Choubey V; Sarkar R; Garg V; Kaushik S; Ghunawat S; Sonthalia S
    Int J Dermatol; 2017 Sep; 56(9):939-943. PubMed ID: 28681382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic modified albumin as a new biomarker in predicting oxidative stress in alopecia areata.
    Ataş H; Gönül M; Öztürk Y; Kavutçu M
    Turk J Med Sci; 2019 Feb; 49(1):129-138. PubMed ID: 30762322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies.
    Guven S; Alver A; Mentese A; Ilhan FC; Calapoglu M; Unsal MA
    Acta Obstet Gynecol Scand; 2009; 88(4):479-82. PubMed ID: 19235558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leptin in Egyptian patients with fibromyalgia syndrome: relation to disease severity.
    Olama SM; Elsaid TO; El-Arman M
    Int J Rheum Dis; 2013 Oct; 16(5):583-9. PubMed ID: 24164847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
    Turk A; Nuhoglu I; Mentese A; Karahan SC; Erdol H; Erem C
    Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls.
    Camkurt MA; Fındıklı E; İzci F; Kurutaş EB; Tuman TC
    Psychiatry Res; 2016 Apr; 238():81-85. PubMed ID: 27086215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
    Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
    Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure.
    Ellidag HY; Eren E; Yılmaz N; Cekin Y
    Redox Rep; 2014 May; 19(3):118-23. PubMed ID: 24620936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer.
    Kilic N; Yavuz Taslipinar M; Guney Y; Tekin E; Onuk E
    Ann Surg Oncol; 2014 Dec; 21(13):4139-43. PubMed ID: 24962940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study.
    Ranzolin A; Duarte AL; Bredemeier M; da Costa Neto CA; Ascoli BM; Wollenhaupt-Aguiar B; Kapczinski F; Xavier RM
    Cytokine; 2016 Aug; 84():25-8. PubMed ID: 27209553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress.
    Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Ersoz HO; Deger O
    Endocr J; 2015; 62(6):493-501. PubMed ID: 25843331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism.
    Cetinkaya A; Kurutas EB; Buyukbese MA; Kantarceken B; Bulbuloglu E
    Mediators Inflamm; 2005 Feb; 2005(1):57-9. PubMed ID: 15770068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.